• LNP-mRNA Vaccine Encoding C. psittaci MOMP Induces Protectio

  2026-06-03

  A recent study demonstrates that a lipid nanoparticle-delivered mRNA vaccine encoding the major outer membrane protein (MOMP) of Chlamydia psittaci can elicit robust humoral and cellular immune responses, significantly reducing pathogen load in BALB/c mice. This work advances the design of mRNA vaccines for zoonotic respiratory pathogens, highlighting the importance of in vitro transcribed, chemically modified mRNA and LNP delivery.

• Dopamine Inhibits Osteoclast Differentiation via cAMP/PKA/CR

  2026-06-02

  Wang et al. reveal a mechanistic pathway by which dopamine suppresses osteoclast differentiation, providing new insight into neuro-skeletal regulation through the cAMP/PKA/CREB axis. This study clarifies how dopaminergic signaling dampens osteoclastogenesis, offering a foundation for future research in bone remodeling and metabolic bone diseases.

• PDHA1 Succinylation Drives Immune Evasion in Cholangiocarcin

  2026-06-02

  This study uncovers how succinylation of PDHA1 at lysine 83 in cholangiocarcinoma alters tumor metabolism, leading to α-ketoglutaric acid accumulation and suppression of macrophage antigen presentation. The findings suggest that targeting PDHA1 succinylation may improve chemotherapeutic response and offers a mechanistic bridge between metabolic reprogramming and immune escape.

• Applied Workflows with FLAG tag Peptide (DYKDDDDK): Protocol

  2026-06-01

  The FLAG tag Peptide (DYKDDDDK) powers high-specificity protein purification and detection, with robust compatibility for streamlined, reproducible workflows. This article translates frontier research and best practices into actionable protocols, troubleshooting, and advanced use-cases for reliable results in complex experimental settings.

• EPZ5676: A Next-Generation DOT1L Inhibitor for Precision Leu

  2026-06-01

  Explore the mechanistic precision and translational potential of EPZ5676, a potent DOT1L inhibitor, in MLL-rearranged leukemia treatment and advanced histone methyltransferase inhibition assays. This article delivers new scientific insights beyond protocol guides and translational overviews.

• Deferoxamine Mesylate: Iron-Chelating Agent in Applied Resea

  2026-05-31

  Deferoxamine mesylate stands out as a powerful iron-chelating agent, enabling researchers to dissect iron’s role in oxidative stress, hypoxia signaling, and metabolic adaptation. Its precise control over cellular iron availability unlocks advanced workflows in cancer, tissue protection, and metabolic stress assays, bridging evidence from nutrient sensing studies to translational protocols.

• Advancing Chondrogenic Staining: Strategic Insights for Tran

  2026-05-30

  This article delivers a deep mechanistic and strategic perspective on optimizing mucopolysaccharide detection and chondrogenic differentiation analysis in translational research using the Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5. Integrating recent primary literature, comparative dye studies, and workflow innovations, it offers actionable guidance for researchers navigating small tissue biopsy challenges, protocol optimization, and the evolving landscape of histological staining solutions.

• NHS-Biotin: Precision Biotinylation for Multimeric Protein S

  2026-05-29

  NHS-Biotin (N-hydroxysuccinimido biotin) enables robust, site-specific protein labeling—crucial for advanced multimeric nanobody engineering and intracellular detection. This article details practical workflows, optimization strategies, and troubleshooting insights, translating recent research into actionable protocols for protein scientists.

• α2-Adrenergic Receptor Activation to Combat Osteosarcoma Rec

  2026-05-29

  A recent study demonstrates that α2-adrenergic receptor agonists, delivered via thermo-sensitive hydrogels, significantly reduce post-surgery osteosarcoma recurrence by modulating the tumor immune microenvironment. This approach highlights an immune-mediated therapeutic mechanism distinct from direct cytotoxicity, offering insights for future strategies in immune rejection modulation.

• CHIR 99021 Trihydrochloride: Precision GSK-3 Inhibitor Workf

  2026-05-28

  CHIR 99021 trihydrochloride enables reproducible control of stem cell fate and metabolic pathway modulation, addressing persistent bottlenecks in organoid, stem cell, and diabetes research. Its application in tunable organoid systems optimizes both scalability and cell diversity, as demonstrated in recent breakthrough studies.

• EPZ5676: Redefining DOT1L Inhibition for Epigenetic Assays

  2026-05-28

  Explore how EPZ5676, a potent DOT1L inhibitor, is transforming histone methylation research and immunomodulatory assay design. Uncover unique insights into its mechanism, selectivity, and practical value for advanced epigenetic studies.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Technic

  2026-05-27

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive, specific detection of rabbit primary antibodies in fluorescence-based immunoassays. It is optimized for workflows such as immunofluorescence, immunocytochemistry, and flow cytometry, but should not be used in applications incompatible with sodium azide or requiring direct conjugation to other detection chemistries.

• Advances in Plant Protein Secretion: Methods and Protocols R

  2026-05-27

  The second edition of 'Plant Protein Secretion: Methods and Protocols' provides a comprehensive and updated framework for investigating protein secretion pathways in plant cells, with emphasis on standardized, reproducible methodologies. Its protocols and comparative analyses offer researchers robust tools for dissecting unique plant secretory features, facilitating advances in molecular plant biology and translational applications.

• AIBP-LRP2–HDL Axis Restricts Stemlike Capillary Expansion in

  2026-05-26

  This study uncovers a regulatory mechanism in which AIBP-LRP2–mediated HDL uptake limits the expansion of CXCR4+ stemlike capillary endothelial cells, thereby modulating collateral circulation in ischemic vascular disease. These insights clarify how dysregulated lipid metabolism and microenvironmental signaling shape revascularization potential, with direct translational implications for therapeutic revascularization.

• Enhancing Small Biopsy Visibility: Dye Models in Pathology L

  2026-05-26

  This article reviews a recent experimental study that assessed the effectiveness of various tissue marking dyes for improving the handling and identification of small biopsy specimens in pathological workflows. The findings highlight hematoxylin's superiority for tissue tracking without diagnostic interference, offering important insights for laboratories managing challenging small sample preparations.

16217 records 1/1082 page Next 12345 下5页 Last page